Call Options

23 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 09, 2023

SELL
$0.6 - $1.53 $5,220 - $13,311
-8,700 Reduced 32.1%
18,400 $11,000
Q2 2023

Aug 11, 2023

SELL
$1.05 - $1.63 $14,490 - $22,494
-13,800 Reduced 33.74%
27,100 $30,000
Q1 2023

May 12, 2023

SELL
$1.2 - $2.73 $36,840 - $83,811
-30,700 Reduced 42.88%
40,900 $5,000
Q4 2022

Feb 14, 2023

BUY
$1.71 - $3.61 $10,431 - $22,021
6,100 Added 9.31%
71,600 $3,000
Q3 2022

Nov 14, 2022

BUY
$1.9 - $8.63 $25,270 - $114,779
13,300 Added 25.48%
65,500 $10,000
Q2 2022

Aug 12, 2022

BUY
$2.13 - $9.01 $23,643 - $100,011
11,100 Added 27.01%
52,200 $4,000
Q1 2022

May 12, 2022

BUY
$6.28 - $15.59 $22,608 - $56,124
3,600 Added 9.6%
41,100 $10,000
Q4 2021

Feb 14, 2022

BUY
$14.7 - $28.67 $283,710 - $553,331
19,300 Added 106.04%
37,500 $19,000
Q3 2021

Nov 10, 2021

BUY
$24.31 - $33.6 $143,429 - $198,240
5,900 Added 47.97%
18,200 $26,000
Q2 2021

Aug 11, 2021

SELL
$26.09 - $40.4 $748,783 - $1.16 Million
-28,700 Reduced 70.0%
12,300 $23,000
Q1 2021

May 14, 2021

SELL
$33.06 - $56.93 $24.5 Million - $42.1 Million
-740,200 Reduced 94.75%
41,000 $177,000
Q4 2020

Feb 16, 2021

BUY
$39.09 - $57.4 $28.6 Million - $42 Million
731,600 Added 1475.0%
781,200 $2.53 Million
Q3 2020

Nov 13, 2020

BUY
$28.43 - $44.67 $528,798 - $830,862
18,600 Added 60.0%
49,600 $818,000
Q2 2020

Aug 10, 2020

BUY
$11.71 - $30.29 $96,022 - $248,378
8,200 Added 35.96%
31,000 $300,000
Q1 2020

May 08, 2020

SELL
$7.64 - $27.5 $40,492 - $145,750
-5,300 Reduced 18.86%
22,800 $27,000
Q4 2019

Feb 11, 2020

SELL
$15.02 - $20.57 $94,626 - $129,591
-6,300 Reduced 18.31%
28,100 $22,000
Q3 2019

Nov 12, 2019

BUY
$18.85 - $27.5 $333,645 - $486,750
17,700 Added 105.99%
34,400 $67,000
Q1 2019

May 10, 2019

SELL
$10.65 - $25.75 $170,400 - $412,000
-16,000 Reduced 48.93%
16,700 $171,000
Q4 2018

Feb 12, 2019

BUY
$9.26 - $16.38 $15,742 - $27,846
1,700 Added 5.48%
32,700 $56,000
Q3 2018

Nov 09, 2018

SELL
$7.54 - $18.31 $173,420 - $421,129
-23,000 Reduced 42.59%
31,000 $221,000
Q2 2018

Aug 13, 2018

SELL
$4.87 - $8.42 $111,523 - $192,818
-22,900 Reduced 29.78%
54,000 $52,000
Q1 2018

May 11, 2018

BUY
$4.69 - $10.05 $241,535 - $517,575
51,500 Added 202.76%
76,900 $16,000
Q4 2017

Feb 09, 2018

BUY
$7.86 - $9.99 $199,644 - $253,746
25,400
25,400 $51,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.